A new cfDNA-based blood test uses AI to detect bladder, prostate, and kidney cancers early, offering a faster, safer, and ...

The FDA approved Cleveland Diagnostics' blood-based test to help diagnose high-grade prostate tumors and aid in biopsy decisions, the company announced.

The decision is supported by evidence from a clinical study and data from supporting analytical validation trials.

Investigators tested the diagnostic performance of Triage Plus for bladder cancer detection in a Veterans affairs population with hematuria.

IsoPSA Test Evaluates Prostate Cancer-Specific Structural Variants of the PSA Protein to Aid in the Diagnosis of High-Grade Prostate Cancer ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

A urological "smell" test for prostate cancer is snaking its way through the R&D process. The University of the West of England's Urological Institute team at Southmead Hospital and the Bristol Royal ...

PSA blood test IsoPSA can correctly rule out high-grade prostate cancer 93% of the time and thus has the potential to reduce the number of unnecessary prostate biopsies. The following article is part ...

Urologists had championed the prostate cancer test in the past It%27s a %22radical change%22 but a welcome one Risks of incontinence%2C impotence and infection are weighed In a major break from the ...

A urological "smell" test for prostate cancer is snaking its way through the R&D process. The University of the West of England's Urological Institute team at Southmead Hospital and the Bristol Royal ...

The American Urological Association has issued guidelines for the management of recurrent UTI for the first time, providing clinicians with recommendations for the evaluation and management of female ...

BALTIMORE, Nov. 18, 2025 (GLOBAL NEWSWIRE) — Today, the American Urological Association (AUA) and the Urology Care Foundation ...